NDC00075-0100-00: THEOPHYLLINE EXTENDED-RELEASE CA.
THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: SLO-BID GYROCAPS BY RORER PHARMACEUTICAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE CAPSULES MODIFIED 100MG 100S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-166-9018, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ANHYDROUS |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| active_medicament_medicinal_strength | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | THEOPHYLLINE CAPSULES MODIFIED 100MG 100S BT |
| capsule_primary_container_content_quantity | 100.000 |
| NSN | 6505-01-166-9018 |
| THERAPEUTIC EQUIVALENT | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | ANHYDROUS |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 100.000 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE CAPSULES MODIFIED 100MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |